European Organisation For Research & Treatment Of Cancer
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
- Conditions
- Prostate Cancer
- Interventions
- Drug: iMABDrug: cMAB
- First Posted Date
- 2023-08-03
- Last Posted Date
- 2025-03-18
- Target Recruit Count
- 1600
- Registration Number
- NCT05974774
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
- Conditions
- First Progression of Glioblastoma
- Interventions
- Radiation: Reirradiation
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2025-05-21
- Target Recruit Count
- 411
- Registration Number
- NCT05904119
- Locations
- 🇦🇹
A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck, Austria
🇦🇹Kepler University Hospital - Neuromed campus, Linz, Austria
🇦🇹Universitaetsklinikum Wien - AKH unikliniken, Vienna, Austria
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
- Conditions
- Oligometastatic Squamous Cell Carcinoma of the Head and Neck
- Interventions
- Radiation: stereotattic ablation radiotherapy (SABR)
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2025-02-05
- Target Recruit Count
- 200
- Registration Number
- NCT05815927
- Locations
- 🇮🇹
AUSL Romagna - AUSL Della Romagna -Ospedale Santa Maria delle Croci, Ravenna, Italy
🇮🇹Azienda ospedaliero Univ Policlinico Umberto I, Rome, Italy
🇪🇸Hospital Universitari Vall d'Hebron -Vall d'Hebron Institut Oncologia, Barcelona, Spain
Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Conditions
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2024-08-27
- Target Recruit Count
- 230
- Registration Number
- NCT05724602
- Locations
- 🇧🇪
Universitair Ziekenhuis Gent, Gent, Belgium
🇸🇮The Institute Of Oncology, Ljubljana, Slovenia
🇳🇴Helse Bergen HF -Haukeland Hospital - Univ. Hosp, Bergen, Norway
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
- Conditions
- HER2-negative Breast CancerStage IIB Breast CancerStage III Breast CancerER-positive Breast Cancer
- Interventions
- First Posted Date
- 2022-08-23
- Last Posted Date
- 2024-01-24
- Target Recruit Count
- 220
- Registration Number
- NCT05512364
- Locations
- 🇧🇪
Institut Jules Bordet, Anderlecht, Belgium
🇧🇪Pole Hospitalier Jolimont - Hopital Jolimont, Haine-Saint-Paul, Belgium
🇧🇪CHU Site Sainte-Elisabeth-UCL Namur, Namur, Belgium
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
- Conditions
- Embryonal TumorGliomaChoroid Plexus TumorTumor of the Sellar RegionPineal TumorMelanocytic Tumor of CNSPineal TumorsHemangiopericytomaGlioneuronal TumorGerm Cell Tumor
- Interventions
- Other: Observational
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2025-01-03
- Target Recruit Count
- 1250
- Registration Number
- NCT05259605
- Locations
- 🇩🇪
Universitaetsklinikum Bonn, Bonn, Germany
🇬🇧NHS Lothian - The Royal Infirmary Of Edinburgh, Edinburgh, United Kingdom
🇦🇹Innsbruck Universitaetsklinik, Innsbruck, Austria
Chemo-free BRCA-targeted Neoadjuvant Strategy
- Conditions
- BRCA2 MutationTNBC - Triple-Negative Breast CancerBRCA1 Mutation
- Interventions
Dissecting the Pathways of Therapy Resistance in Early Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Procedure: collection of the biopsy, blood samples
- First Posted Date
- 2021-08-09
- Last Posted Date
- 2024-02-22
- Target Recruit Count
- 31
- Registration Number
- NCT04995575
- Locations
- 🇧🇪
CHU-UCL Namur - CHU Site Sainte-Elisabeth-UCL Namur, Namur, Belgium
🇧🇪Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium
🇧🇪Hopital De Jolimont, Haine-Saint-Paul, Belgium
Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
- Conditions
- First Progression of MGMT Promoter-methylated Glioblastoma
- Interventions
- Locations
- 🇪🇸
Hospital Universitario Ramon y Cajal, Madrid, Spain
🇪🇸Hospital Universitario 12 De Octubre, Madrid, Spain
🇨🇭UniversitaetsSpital, Zürich, Switzerland
Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer
- Conditions
- Platinum-Sensitive Biliary Tract Cancer
- Interventions